Clinical Trial

Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102

Name: Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102 — clinical trial record (NCT07527975)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

Long-Term Follow-up: Phase I/II clinical study to evaluate the safety and efficacy of the infusion of RP-L102

Trial Details

NCT Number	NCT07527975
Lead Sponsor	Rocket Pharmaceuticals Inc.
Conditions	Fanconi Anemia
Enrollment	14 participants
Start Date	2022-02-01
Primary Completion	2038-05 (estimated)
Study Completion	2038-05 (estimated)
Updated on ClinicalTrials.gov	2026-04-14